The Changing Landscape of VTE Treatment
May 21, 2014|Federal Practitioner
Author and Disclosure Information
Watch as Kenneth A. Bauer, MD, discusses the new venous thromboembolism (VTE) oral agents and their impact on the future of care for patients with cancer.
For more presentations from the 9th Annual Meeting of the Association of VA Hematology/Oncology (AVAHO), click here: AVAHO Meeting Presentations